Use of parenteral testosterone prior to hypospadias surgery

C. C. Luo, J. N. Lin, C. H. Chiu, F. S. Lo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Surgical correction of genital defects was formerly proposed when the size of the penis was sufficient to permit easy surgical repair. To enlarge penile size, temporary stimulation with testosterone or dihydrotestosterone cream has been used; however, the results were not only inconsistent, but absorption was also variable. We report our experience with parenteral testosterone as an adjunct to reconstructive genital surgery in 25 patients aged 6-18 months from July 1999 to December 2000, including 8 with penile hypospadias, 15 with penoscrotal hypospadias, and 2 with perineal hypospadias. Each had a penis that was significantly smaller than usual. Testosterone enanthate 25 mg was given i.m. once per month for a total of three doses before surgical repair. Penile length and glans circumference were measured before therapy and at operation. Side effects such as the development of pubic hair and acne were monitored. Bone age was checked 1 year later. An increase in penile length (from 19.8 ± 2.4 mm to 23.8 ± 2.0 mm) and glans circumference (from 27.4 ± 1.4 mm to 37.84 ± 2.6 mm) was apparent in all except 2 patients (P <0.001 for both, paired t-test). Four patients had a significant increase in either penile length or glans circumference after the initial dose so that no further injections were required. No definite secondary effects were found. Preoperative parenteral testosterone therapy thus causes a significant increase in penile length and glans circumference without apparent side effects. We suggest that this therapy prior to microphallic hypospadias repair is appropriate.

Original languageEnglish
Pages (from-to)82-84
Number of pages3
JournalPediatric Surgery International
Volume19
Issue number1-2
Publication statusPublished - Apr 2003
Externally publishedYes

Fingerprint

Hypospadias
Testosterone
Penis
Reconstructive Surgical Procedures
Dihydrotestosterone
Acne Vulgaris
Hair
Therapeutics
Bone and Bones
Injections

Keywords

  • Hypospadias
  • Microphallus
  • Testosterone

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Luo, C. C., Lin, J. N., Chiu, C. H., & Lo, F. S. (2003). Use of parenteral testosterone prior to hypospadias surgery. Pediatric Surgery International, 19(1-2), 82-84.

Use of parenteral testosterone prior to hypospadias surgery. / Luo, C. C.; Lin, J. N.; Chiu, C. H.; Lo, F. S.

In: Pediatric Surgery International, Vol. 19, No. 1-2, 04.2003, p. 82-84.

Research output: Contribution to journalArticle

Luo, CC, Lin, JN, Chiu, CH & Lo, FS 2003, 'Use of parenteral testosterone prior to hypospadias surgery', Pediatric Surgery International, vol. 19, no. 1-2, pp. 82-84.
Luo, C. C. ; Lin, J. N. ; Chiu, C. H. ; Lo, F. S. / Use of parenteral testosterone prior to hypospadias surgery. In: Pediatric Surgery International. 2003 ; Vol. 19, No. 1-2. pp. 82-84.
@article{fcd2b6c0ce0a4cb19f937174dc248321,
title = "Use of parenteral testosterone prior to hypospadias surgery",
abstract = "Surgical correction of genital defects was formerly proposed when the size of the penis was sufficient to permit easy surgical repair. To enlarge penile size, temporary stimulation with testosterone or dihydrotestosterone cream has been used; however, the results were not only inconsistent, but absorption was also variable. We report our experience with parenteral testosterone as an adjunct to reconstructive genital surgery in 25 patients aged 6-18 months from July 1999 to December 2000, including 8 with penile hypospadias, 15 with penoscrotal hypospadias, and 2 with perineal hypospadias. Each had a penis that was significantly smaller than usual. Testosterone enanthate 25 mg was given i.m. once per month for a total of three doses before surgical repair. Penile length and glans circumference were measured before therapy and at operation. Side effects such as the development of pubic hair and acne were monitored. Bone age was checked 1 year later. An increase in penile length (from 19.8 ± 2.4 mm to 23.8 ± 2.0 mm) and glans circumference (from 27.4 ± 1.4 mm to 37.84 ± 2.6 mm) was apparent in all except 2 patients (P <0.001 for both, paired t-test). Four patients had a significant increase in either penile length or glans circumference after the initial dose so that no further injections were required. No definite secondary effects were found. Preoperative parenteral testosterone therapy thus causes a significant increase in penile length and glans circumference without apparent side effects. We suggest that this therapy prior to microphallic hypospadias repair is appropriate.",
keywords = "Hypospadias, Microphallus, Testosterone",
author = "Luo, {C. C.} and Lin, {J. N.} and Chiu, {C. H.} and Lo, {F. S.}",
year = "2003",
month = "4",
language = "English",
volume = "19",
pages = "82--84",
journal = "Pediatric Surgery International",
issn = "0179-0358",
publisher = "Springer Verlag",
number = "1-2",

}

TY - JOUR

T1 - Use of parenteral testosterone prior to hypospadias surgery

AU - Luo, C. C.

AU - Lin, J. N.

AU - Chiu, C. H.

AU - Lo, F. S.

PY - 2003/4

Y1 - 2003/4

N2 - Surgical correction of genital defects was formerly proposed when the size of the penis was sufficient to permit easy surgical repair. To enlarge penile size, temporary stimulation with testosterone or dihydrotestosterone cream has been used; however, the results were not only inconsistent, but absorption was also variable. We report our experience with parenteral testosterone as an adjunct to reconstructive genital surgery in 25 patients aged 6-18 months from July 1999 to December 2000, including 8 with penile hypospadias, 15 with penoscrotal hypospadias, and 2 with perineal hypospadias. Each had a penis that was significantly smaller than usual. Testosterone enanthate 25 mg was given i.m. once per month for a total of three doses before surgical repair. Penile length and glans circumference were measured before therapy and at operation. Side effects such as the development of pubic hair and acne were monitored. Bone age was checked 1 year later. An increase in penile length (from 19.8 ± 2.4 mm to 23.8 ± 2.0 mm) and glans circumference (from 27.4 ± 1.4 mm to 37.84 ± 2.6 mm) was apparent in all except 2 patients (P <0.001 for both, paired t-test). Four patients had a significant increase in either penile length or glans circumference after the initial dose so that no further injections were required. No definite secondary effects were found. Preoperative parenteral testosterone therapy thus causes a significant increase in penile length and glans circumference without apparent side effects. We suggest that this therapy prior to microphallic hypospadias repair is appropriate.

AB - Surgical correction of genital defects was formerly proposed when the size of the penis was sufficient to permit easy surgical repair. To enlarge penile size, temporary stimulation with testosterone or dihydrotestosterone cream has been used; however, the results were not only inconsistent, but absorption was also variable. We report our experience with parenteral testosterone as an adjunct to reconstructive genital surgery in 25 patients aged 6-18 months from July 1999 to December 2000, including 8 with penile hypospadias, 15 with penoscrotal hypospadias, and 2 with perineal hypospadias. Each had a penis that was significantly smaller than usual. Testosterone enanthate 25 mg was given i.m. once per month for a total of three doses before surgical repair. Penile length and glans circumference were measured before therapy and at operation. Side effects such as the development of pubic hair and acne were monitored. Bone age was checked 1 year later. An increase in penile length (from 19.8 ± 2.4 mm to 23.8 ± 2.0 mm) and glans circumference (from 27.4 ± 1.4 mm to 37.84 ± 2.6 mm) was apparent in all except 2 patients (P <0.001 for both, paired t-test). Four patients had a significant increase in either penile length or glans circumference after the initial dose so that no further injections were required. No definite secondary effects were found. Preoperative parenteral testosterone therapy thus causes a significant increase in penile length and glans circumference without apparent side effects. We suggest that this therapy prior to microphallic hypospadias repair is appropriate.

KW - Hypospadias

KW - Microphallus

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0038517740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038517740&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 82

EP - 84

JO - Pediatric Surgery International

JF - Pediatric Surgery International

SN - 0179-0358

IS - 1-2

ER -